title: Blood stem cells autografts in patients with high risk multiple myeloma.
abstract: Five patients with high risk multiple myeloma not responsive to standard chemotherapy were treated by high-dose chemotherapy (Melphalan, Cyclophosphamide) (HDC) and total body irradiation (TBI) followed by autografting with blood stem cells. These cells were previously collected by leukaphereses from eight to twelve occasions during hematopoietic recovery following profound aplasia induced by each course of intensive chemotherapy (Vincristine, Adriamycin, Cyclosphosphamide, Prednisone) when the patient reached a neutrophil count of 1,000/microliters and a platelet count of 100,000/microliters. No patients had evidence of tumor plasmacells in leukaphereses products using cytology, immunocytochemistry and immunofluorescence. At this time the patient 5 is not evaluable because of the short follow-up. One died at day 30 from heart failure. All living patients achieved a complete remission which persisted at a follow-up of 300, 261 and 136 days. Autologous blood derived hematopoietic stem cells induced successful and sustained engraftment in all living patients. Our results indicate the feasibility of this therapeutic approach over allogenic or autologous bone marrow transplantation in selected patients with high tumour mass multiple myeloma.
authors.affiliation: Divisione di Ematologia, Ospedale San Camillo, Roma, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Montuoro
authors.forename: L
authors.initials: L
authors.lastname: De Rosa
authors.forename: V
authors.initials: V
authors.lastname: Zoli
authors.forename: A
authors.initials: A
authors.lastname: Pandolfi
authors.forename: M
authors.initials: M
authors.lastname: Cossutta
authors.forename: T
authors.initials: T
authors.lastname: Lanti
authors.forename: A
authors.initials: A
authors.lastname: De Laurenzi
mesh_terms: D000328:Adult; D001804:Blood Transfusion, Autologous / Q000379:methods*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D012189:Retrospective Studies; D012307:Risk Factors